Please assess the completion status of the following clinical trial:

Trial Title: Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria~* Subjects whose depressive symptoms have not remitted during their participation in the Pharmacokinetics and Pharmacodynamics of Citalopram and Escitalopram study or the Pharmacokinetics and Pharmacodynamics of Duloxetine study~* Must be able to continue to take same dose of duloxetine through the course of the study~Exclusion Criteria~* A history of failure for respond to Electroconvulsive Therapy (ECT)~* Any metal in the head (except in mouth)~* Implanted medication pump or cardiac pacemaker~* Have had prior brain surgery~* Have unprovoked seizure disorder or family history of treatment resistant epilepsy~* Pregnancy~* Psychiatric hospitalization within the past two weeks~* Suicide attempt with hospitalization within past three months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Repetitive Transcranial Magnetic Stimulation (Type: EXPERIMENTAL): All subjects will receive 10 Hz repetitive transcranial magnetic stimulation (rTMS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for a fixed-flexible period of 5 treatments per week for up to 6 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).